claiming they will limit access to much-needed drugs and discourage drug companies from investing in Canada. But drug policy experts say the changes, which the government estimates will yield …
Drug policy experts accuse industry and patient groups of ‘fearmongering’ with concerns about new drug-pricing rules
Drug policy experts accuse industry and patient groups of ‘fearmongering’ with concerns about new drug-pricing rules
Leave a reply